$15.48
0.211.38%
al cierre: -
$15.57
0.090.58%
After hour: Oct 31, 7:59 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
ADMA Biologics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 5
Estimación de BPA
$0.160
Estimación de ingresos trimestrales
$130.36M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$474.17M
Analice el historial de beneficios de ADMA Biologics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA | ADMA Biologics | $0.15 | $0.16 | — | — | $119.84M | $130.36M | — | — | 11/05/2025 | |
ADMA | ADMA Biologics | $0.13 | $0.14 | $0.14 | 0.00% | $107.19M | $121.50M | $121.98M | 0.40% | 08/06/2025 | |
ADMA | ADMA Biologics | $0.08 | $0.14 | $0.14 | 0.00% | $81.88M | $116.40M | $114.80M | -1.37% | 05/07/2025 | |
ADMA | ADMA Biologics | $0.04 | $0.15 | $0.14 | -6.67% | $73.90M | $112.80M | $117.55M | 4.21% | 03/03/2025 | |
ADMA | ADMA Biologics | $0.01 | $0.13 | $0.15 | 15.38% | $67.28M | $105.85M | $119.84M | 13.22% | 11/07/2024 | |
ADMA | ADMA Biologics | -$0.03 | $0.08 | $0.13 | 62.50% | $60.12M | $86.41M | $107.19M | 24.05% | 08/08/2024 | |
ADMA | ADMA Biologics | -$0.03 | $0.05 | $0.08 | 60.00% | $56.91M | $77.27M | $81.88M | 5.96% | 05/09/2024 | |
ADMA | ADMA Biologics | -$0.06 | $0.02 | $0.04 | 100.00% | $49.98M | $72.15M | $73.90M | 2.43% | 02/28/2024 | |
ADMA | ADMA Biologics | -$0.08 | -$0.01 | $0.01 | 200.00% | $41.09M | $62.12M | $67.28M | 8.30% | 11/08/2023 | |
ADMA | ADMA Biologics | -$0.07 | -$0.02 | -$0.03 | -50.00% | $33.91M | $55.50M | $60.12M | 8.33% | 08/09/2023 | |
ADMA | ADMA Biologics | -$0.10 | -$0.04 | -$0.03 | 25.00% | $29.10M | $53.41M | $56.91M | 6.56% | 05/10/2023 | |
ADMA | ADMA Biologics | -$0.09 | -$0.06 | -$0.06 | 0.00% | $26.38M | $45.93M | $49.98M | 8.82% | 03/23/2023 | |
ADMA | ADMA Biologics | -$0.13 | -$0.08 | -$0.08 | 0.00% | $20.68M | $34.48M | $41.09M | 19.17% | 11/09/2022 | |
ADMA | ADMA Biologics | -$0.14 | -$0.08 | -$0.07 | 12.50% | $17.83M | $31.81M | $33.91M | 6.59% | 08/10/2022 | |
ADMA | ADMA Biologics | -$0.16 | -$0.08 | -$0.10 | -25.00% | $16.05M | $27.69M | $29.10M | 5.10% | 05/11/2022 | |
ADMA | ADMA Biologics | -$0.21 | -$0.09 | -$0.09 | 0.00% | $13.96M | $21.76M | $26.38M | 21.25% | 03/24/2022 | |
ADMA | ADMA Biologics | -$0.19 | -$0.14 | -$0.13 | 7.14% | $10.28M | $18.72M | $20.68M | 10.48% | 11/10/2021 | |
ADMA | ADMA Biologics | -$0.23 | -$0.15 | -$0.14 | 6.67% | $7.79M | $16.42M | $17.83M | 8.59% | 08/11/2021 | |
ADMA | ADMA Biologics | -$0.26 | -$0.17 | -$0.16 | 5.88% | $10.20M | $14.58M | $16.05M | 10.08% | 05/12/2021 | |
ADMA | ADMA Biologics | -$0.18 | -$0.16 | -$0.21 | -31.25% | $12.04M | $12.91M | $13.96M | 8.10% | 03/25/2021 | |
ADMA | ADMA Biologics | -$0.19 | -$0.19 | -$0.19 | 0.00% | $7.22M | $9.96M | $10.28M | 3.17% | 11/05/2020 |
ADMA Biologics (ADMA) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $0.14 | $0.14 | 0.00 % |
| Q1 | 2025-05-07 | $0.14 | $0.14 | 0.00 % |
| Q4 | 2025-03-03 | $0.14 | $0.15 | -6.67 % |
| Q3 | 2024-11-07 | $0.15 | $0.13 | 15.4 % |
ADMA Biologics (ADMA) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $121.98M | $121.50M | 0.40 % |
| Q1 | 2025-05-07 | $114.80M | $116.40M | -1.37 % |
| Q4 | 2025-03-03 | $117.55M | $112.80M | 4.21 % |
| Q3 | 2024-11-07 | $119.84M | $105.85M | 13.2 % |
PREGUNTAS FRECUENTES
¿Cuándo ADMA Biologics (NASDAQ:ADMA) publicará los resultados?
Está previsto que ADMA Biologics (ADMA) presente resultados el noviembre 5, 2025. Los últimos resultados se publicaron el agosto 6, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de ADMA Biologics (NASDAQ:ADMA)?
El BPA real fue de $0.14, que alcanzó la estimación de $0.14.
¿Cuáles fueron los ingresos de ADMA Biologics (NASDAQ:ADMA)?
Los ingresos reales fueron $122M, que superó la estimación de $121.5M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.